Drug Topics July 15, 2024
Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.
During the COVID-19 pandemic years of 2021 and 2022, health care and medication affordability improved for low-income adults compared to pre-pandemic affordability, further tightening the gap between low- and high-income individuals, according to research published in JAMA Health Forum.1
However, upon discovering these results, researchers claim that the conclusion of health care policies allowing affordability during COVID-19—while unemployment and economic loss increased—could be detrimental to the health care economy going forward.
“The onset of the COVID-19 pandemic in the US led to a dramatic rise in unemployment, which disproportionately impacted low-income adults. As a result, millions of people experienced economic loss, deepening financial strain, and...
Today's Sponsors
Today's Sponsor